Patents by Inventor Andre C. B. Lucassen

Andre C. B. Lucassen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160199389
    Abstract: The invention relates to compositions and formulations comprising isolated acidic fraction of mastic gum and uses thereof for treating impaired neurological functions as well as wound and tissue repair.
    Type: Application
    Filed: January 19, 2016
    Publication date: July 14, 2016
    Applicant: REGENERA PHARMA LTD.
    Inventors: Zadik Hazan, Andre C. B. Lucassen
  • Patent number: 9271949
    Abstract: The invention relates to compositions and formulations comprising isolated acidic fraction of mastic gum and uses thereof for treating impaired neurological functions as well as wound and tissue repair.
    Type: Grant
    Filed: September 7, 2011
    Date of Patent: March 1, 2016
    Assignee: REGENERA PHARMA LTD.
    Inventors: Zadik Hazan, Andre C. B. Lucassen
  • Patent number: 8637575
    Abstract: The present invention provides new tyrphostin derivatives acting as protein kinase (PK) and receptor kinase (RK) signaling modulators. The invention further provides methods of their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for preventions and treatments of PK and RK related disorders such as metabolic, inflammatory, fibrotic, and cell proliferative disorders, in particular cancer.
    Type: Grant
    Filed: June 7, 2009
    Date of Patent: January 28, 2014
    Assignee: Novotyr Therapeutics Ltd.
    Inventors: Hadas Reuveni, Alexander Levitzki, Revital Sasson, Andre C. B. Lucassen
  • Patent number: 8536227
    Abstract: The present invention provides new tyrphostin derivatives acting as protein kinase (PK) and receptor kinase (RK) signaling modulators. The invention further provides methods of their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for preventions and treatments of PK and RK related disorders such as metabolic, inflammatory, fibrotic, and cell proliferative disorders, in particular cancer.
    Type: Grant
    Filed: June 7, 2009
    Date of Patent: September 17, 2013
    Assignee: Novotyr Therapeutics Ltd.
    Inventors: Hadas Reuveni, Alexander Levitzki, Revital Sasson, Andre C. B. Lucassen
  • Publication number: 20130172416
    Abstract: The invention relates to compositions and formulations comprising isolated acidic fraction of mastic gum and uses thereof for treating impaired neurological functions as well as wound and tissue repair.
    Type: Application
    Filed: September 7, 2011
    Publication date: July 4, 2013
    Applicant: REGENERA PHARMA LTD.
    Inventors: Zadik Hazan, Andre C. B. Lucassen
  • Publication number: 20110105618
    Abstract: The present invention provides new tyrphostin derivatives acting as protein kinase (PK) and receptor kinase (RK) signaling modulators. The invention further provides methods of their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for preventions and treatments of PK and RK related disorders such as metabolic, inflammatory, fibrotic, and cell proliferative disorders, in particular cancer.
    Type: Application
    Filed: June 7, 2009
    Publication date: May 5, 2011
    Applicant: NOVOTYR THERAPEUTICS LTD.
    Inventors: Hadas Reuveni, Alexander Levitzki, Revital Sasson, Andre C. B. Lucassen